These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19748437)

  • 1. Specific IgG avidity in active and inactive human neurocysticercosis.
    Manhani MN; da Silva Ribeiro V; Oliveira Silva DA; Costa-Cruz JM
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):211-3. PubMed ID: 19748437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal synthesis of specific immunoglobulin G antibodies in neurocysticercosis: evaluation of antibody concentrations by enzyme-linked immunosorbent assay using a whole cysticercal extract and cyst vesicular fluid as antigens.
    Arruda GC; Quagliato EM; Rossi CL
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):45-9. PubMed ID: 16290026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific IgG avidity in acute and chronic human fascioliasis.
    Abou-Basha LM; Shehab AY; Osman MM; Farag HF
    East Mediterr Health J; 2000; 6(5-6):919-25. PubMed ID: 12197349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific phage-displayed peptides discriminate different forms of neurocysticercosis by antibody detection in the serum samples.
    Manhani MN; Ribeiro VS; Cardoso R; Ueira-Vieira C; Goulart LR; Costa-Cruz JM
    Parasite Immunol; 2011 Jun; 33(6):322-9. PubMed ID: 21323932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the relative avidity of the specific IgG antibodies in human toxocariasis.
    Dziemian E; Zarnowska H; Kołodziej-Sobocińska M; Machnicka B
    Parasite Immunol; 2008 Mar; 30(3):187-90. PubMed ID: 18179629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of specific immunoglobulin G antibody avidity in the differential diagnosis of active and chronic Toxocara canis infections].
    Rychlicki W
    Wiad Parazytol; 2004; 50(2):229-36. PubMed ID: 16859028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antigenic fractions of varying hydrophobicity from Taenia solium metacestodes for the diagnosis of human neurocysticercosis.
    Machado GA; Santiago FM; Mineo JR; Costa-Cruz JM
    Trop Med Int Health; 2007 Nov; 12(11):1369-76. PubMed ID: 17949403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA detection in human neurocysticercosis using different preparations of heterologous antigen.
    da S Ribeiro V; Manhani MN; Costa-Cruz JM
    Parasitol Res; 2010 Jun; 107(1):221-5. PubMed ID: 20386922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocysticercosis in clinically suspected and MRI proven cases: evidence of sub-optimal antibody response.
    Kishore J; Mukhopadhyay C; Pradhan S; Ayyagari A; Gupta RK
    Indian J Pathol Microbiol; 2004 Apr; 47(2):290-4. PubMed ID: 16295505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Particularities of the immune response in neurocysticercosis].
    Andriantsimahavandy A; Esterre P; Michault A; Raobelison A; Guyon P; Chabrier X; Lapprand M
    Arch Inst Pasteur Madagascar; 1996; 63(1-2):31-3. PubMed ID: 12463012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an IgG-ELISA strategy using Taenia solium metacestode somatic and excretory-secretory antigens for diagnosis of neurocysticercosis revealing biological stage of the larvae.
    Sahu PS; Parija SC; Narayan SK; Kumar D
    Acta Trop; 2009 Apr; 110(1):38-45. PubMed ID: 19183550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of intrathecal synthesis of IgG in neurocysticercosis.
    Minelli C; Takayanagui OM
    J Neurol Sci; 2005 Nov; 238(1-2):83-6. PubMed ID: 16125726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles.
    Chavarría A; Fleury A; García E; Márquez C; Fragoso G; Sciutto E
    Clin Immunol; 2005 Sep; 116(3):271-8. PubMed ID: 15935735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Vidas assay for Toxoplasma-specific IgG avidity: evaluation on 603 sera.
    Fricker-Hidalgo H; Saddoux C; Suchel-Jambon AS; Romand S; Foussadier A; Pelloux H; Thulliez P
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):167-72. PubMed ID: 16725296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of antibody avidity in BALB/c mice infected with Toxocara canis.
    Fenoy S; Rodero M; Pons E; Aguila C; Cuéllar C
    Parasitology; 2008 May; 135(6):725-33. PubMed ID: 18413003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of toxoplasmosis in pregnancy: importance of immunoglobulin G avidity test.
    Olariu TR; Creţu O; Koreck A; Petrescu C
    Roum Arch Microbiol Immunol; 2006; 65(3-4):131-4. PubMed ID: 18389729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of neurocysticercosis in the foothills of the Himalayas.
    Kumar A; Khan SA; Khan S; Das S; Anurag ; Negi KS
    Int J Infect Dis; 2006 Jan; 10(1):79-82. PubMed ID: 16289788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
    Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
    East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed diagnostic criteria for neurocysticercosis.
    Katti MK
    Neurology; 2002 Apr; 58(8):1315; author reply 1315-6. PubMed ID: 11973827
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparisons between scolex and membrane antigens of Cysticercus fasciolaris and Cysticercus cellulosae larvae for immunodiagnosis of neurocysticercosis.
    Shukla N; Husain N; Jyotsna ; Gupta S; Husain M
    J Microbiol Immunol Infect; 2008 Dec; 41(6):519-24. PubMed ID: 19255697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.